Qian, Hong-jie
Wang, Yu
Zhang, Meng-qi
Xie, Yuan-chao
Wu, Qing-qing
Liang, Li-yu
Cao, Ye
Duan, Hua-qing
Tian, Guang-hui
Ma, Juan
Zhang, Zhuo-bing
Li, Ning
Jia, Jing-ying
Zhang, Jing
Aisa, Haji Akber
Shen, Jing-shan
Yu, Chen
Jiang, Hua-liang
Zhang, Wen-hong
Wang, Zhen
Liu, Gang-yi
Article History
Received: 18 February 2022
Accepted: 3 March 2022
First Online: 16 March 2022
Competing interests
: HQD and GHT are the employees of Vigonvita Life Science Co., Ltd, the sponsor of the study. JM, ZBZ, and NL are the employees of Shanghai Junshi Biosciences Co., Ltd., the parent company of the co-sponsor Shanghai JunTop Biosciences Co., Ltd. YCX, JSS, and HLJ filed a patent application on antiviral nucleoside analogs. The remaining authors declare no competing interests.